Have a personal or library account? Click to login
What proteins and albumins in bronchoalveolar lavage fluid and serum could tell us in COVID-19 and influenza acute respiratory distress syndrome on mechanical ventilation patient - A prospective double center study Cover

What proteins and albumins in bronchoalveolar lavage fluid and serum could tell us in COVID-19 and influenza acute respiratory distress syndrome on mechanical ventilation patient - A prospective double center study

Open Access
|Jan 2025

References

  1. Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and Outcomes of Acute Lung Injury. New England Journalof Medicine. 2005; 353(16), 1685–1693.
  2. Pelosi P, D'Onofrio D, Chiumello D, et al. Pulmonary and extrapulmonary acute respiratory distress syndrome are different. Eur Respir J Suppl. 2003; 42:48s–56s.
  3. Ashbaugh DG, Bigelow DB, Petty TL, et al. Acute respiratory distress in adults. Lancet. 1967; 12;2(7511):319–23.
  4. Ranieri VM, Rubenfeld GD, Thompson B, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012; 20;307(23):2526–33.
  5. Katzenstein AL, Bloor CM, Leibow AA. Diffuse alveolar damage-the role of oxygen, shock, and related factors. A review. Am J Pathol. 1976;85(1):209–28.
  6. Tomashefski JF Jr. Pulmonary pathology of acute respiratory distress syndrome.
  7. Clin Chest Med. 2000;21(3):435–66. 2000,
  8. Gattinoni L, Pesenti A. The concept of “baby lung”. Intensive Care Med. 2005;31(6):776–84.
  9. Bain W, Yang H, Shah FA, et al. COVID-19 versus Non-COVID ARDS: Comparison of Demographics, Physiologic Parameters, Inflammatory Biomarkers and Clinical Outcomes. Ann Am Thorac Soc. 2021; 18(7):1202–1210.
  10. Vincent JL, Slutsky AS. We've never seen a patient with ARDS! Intensive Care Med. 2021; 46, 2133–2135.
  11. Wang Y, Wang H, Zhang C, et al. Lung fluid biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis. Critical Care. 2019; 23(1).
  12. Farjanel J, Hartmann DJ, Guidet B, et al. Four Markers of Collagen Metabolism as Possible Indicators of Disease in the Adult Respiratory Distress Syndrome. American Review of Respiratory Disease. 1993; 147(5), 1091–1099.
  13. Nakos G, Pneumatikos J, Tsangaris I, et al. Proteins and phospholipids in BAL from patients with hydrostatic pulmonary oedema. American Journal of Respiratory and Critical Care Medicine. 1997; 155(3), 945–951.
  14. Karagiorga G, Nakos G, Galiatsou E, et al. Biochemical parameters of bronchoalveolar lavage fluid in fat embolism. Intensive Care Med. 2006; 32(1):116–23.
  15. Martin TR, Rubenfeld GD, Ruzinski JT, et al. Relationship between soluble CD14, lipopolysaccharide-binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndrome. Am J RespirCrit Care Med. 1997;155(3):937–44.
  16. Wang Y, Wang H, Zhang C, et al. Lung fluid biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis. Critical Care. 2019; 23(1):43.
  17. Mangialardi R.J., Martin G.S., Bernard G.R., et al. Hypoproteinemia predicts acute respiratory distress syndrome development, weight gain, and death in patients with sepsis. Crit Care Med. 2000;28:3137–45.
  18. Hoeboer SH, Straaten HMO, Groeneveld AJ. Albumin rather than C-reactive protein may be valuable in predicting and monitoring the severity and course of acute respiratory distress syndrome in critically ill patients with or at risk for the syndrome after new onset fever. BMC Pulmonary Medicine. 2015; 15(1).
  19. Tiruneh SA, Tesema ZT, Azanaw MM, et al. The effect of age on the incidence of COVID-19 complications: a systematic review and meta-analysis. Syst Rev. 2021; 20;10(1):80.
  20. Ramírez P, Gordón M, Martín-Cerezuela M, et al. Acute respiratory distress syndrome due to COVID-19. Clinical and prognostic features from a medical Critical Care Unit in Valencia, Spain. Medicina Intensiva (Engl Ed). 2021;45(1):27–34.
  21. Tang X, Du R, Wang R, et al. Comparison of Hospitalized Patients with Acute Respiratory Distress Syndrome Caused by COVID-19 and H1N1. Chest. 2020; 158(1):195–205.
  22. Gebhard C, Regitz-Zagrosek VK, Neuhauser H, et al. Impact of sex and gender on COVID-19 outcomes in Europe. Biology of Sex Differences. 2020; 11(1):29.
  23. Kovacevic P, Matijasevic J, Dragic S, et al. Characteristics and Outcomes of Critically Ill Patients with Influenza A (H1N1) in the Western Balkans during the 2019 Post-Pandemic Season. Indian Journal of Medical Microbiology. 2020; 38(3–4), 415–420.
  24. Cordero A, Santos García-Gallego C, Bertomeu-González V, et al. Mortality associated with cardiovascular disease in patients with COVID-19. Rec. Cardioclinics. 2021;56(1):30–8.
  25. Sasson I. Age and COVID-19 mortality: A comparison of Gompertz doubling time across and causes of death. Demographic Research. 2021; 396–VOLUME 44:16:379-
DOI: https://doi.org/10.2478/jccm-2025-0005 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Language: English
Page range: 64 - 69
Submitted on: Mar 8, 2024
Accepted on: Jan 8, 2025
Published on: Jan 31, 2025
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 Anita Djurdjevic Svraka, Dragan Svraka, Bosa Mrjanic Azaric, Jovana Malic, Goran Baric, Pedja Kovacevic, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.